Skip to main content

Compare Stocks

Date Range: 

 Heron TherapeuticsMyovant SciencesADC TherapeuticsHarmony BiosciencesGeneration Bio
SymbolNASDAQ:HRTXNYSE:MYOVNYSE:ADCTNASDAQ:HRMYNASDAQ:GBIO
Price Information
Current Price$14.21$22.17$21.64$31.70$31.50
52 Week RangeBuyHoldBuyBuyBuy
MarketRank™
Overall Score1.71.31.71.41.8
Analysis Score3.43.23.43.53.5
Community Score2.72.63.82.13.8
Dividend Score0.00.00.00.00.0
Ownership Score1.70.00.80.80.8
Earnings & Valuation Score0.60.60.60.60.6
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$27.50$31.57$48.75$51.67$40.60
% Upside from Price Target93.53% upside42.41% upside125.28% upside62.99% upside28.89% upside
Trade Information
Market Cap$1.38 billion$2.00 billion$1.48 billion$1.70 billion$1.75 billion
Beta1.522.99N/AN/AN/A
Average Volume1,258,420888,292327,142136,360603,823
Sales & Book Value
Annual Revenue$145.97 millionN/A$2.34 millionN/AN/A
Price / Sales9.91N/A637.10N/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$4.48 per share($1.21) per shareN/AN/AN/A
Price / Book3.17N/AN/AN/A
Profitability
Net Income$-204,750,000.00$-288,990,000.00$-116,480,000.00N/AN/A
EPS($2.50)($3.37)($2.36)N/AN/A
Trailing P/E RatioN/AN/AN/A0.000.00
Forward P/E RatioN/AN/AN/A27.33N/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-216.18%N/AN/AN/AN/A
Return on Equity (ROE)-65.06%N/AN/AN/AN/A
Return on Assets (ROA)-49.14%-201.20%N/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.28%2.04%N/A
Current Ratio3.60%1.75%15.55%7.87%31.19%
Quick Ratio3.16%1.75%15.55%7.80%31.19%
Ownership Information
Institutional Ownership Percentage99.01%33.77%40.88%50.17%63.26%
Insider Ownership Percentage12.85%3.90%N/AN/AN/A
Miscellaneous
Employees223214208150100
Shares Outstanding101.83 million91.48 million68.89 million56.90 million56.59 million
Next Earnings Date8/4/2021 (Estimated)8/10/2021 (Estimated)8/17/2021 (Estimated)8/10/2021 (Estimated)8/10/2021 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
Generation Bio (NASDAQ:GBIO) Trading Down 2.8%Generation Bio (NASDAQ:GBIO) Trading Down 2.8%
americanbankingnews.com - May 18 at 12:00 PM
Oxurion NV: OXURION NV Appoints Tom Graney, CFA as Chief Executive OfficerOxurion NV: OXURION NV Appoints Tom Graney, CFA as Chief Executive Officer
finanznachrichten.de - May 17 at 3:29 AM
OXURION NV Appoints Tom Graney, CFA as Chief Executive OfficerOXURION NV Appoints Tom Graney, CFA as Chief Executive Officer
apnews.com - May 17 at 3:29 AM
Carbon Fiber in Automotive Market Research Report by Component, by Material - United States Forecast to 2025 - Cumulative Impact of COVID-19Carbon Fiber in Automotive Market Research Report by Component, by Material - United States Forecast to 2025 - Cumulative Impact of COVID-19
au.finance.yahoo.com - May 14 at 10:31 PM
Generation Bio (NASDAQ:GBIO) Announces Quarterly  Earnings Results, Misses Estimates By $0.01 EPSGeneration Bio (NASDAQ:GBIO) Announces Quarterly Earnings Results, Misses Estimates By $0.01 EPS
americanbankingnews.com - May 13 at 12:28 PM
Generation Bio Co. (NASDAQ:GBIO) Insider Sells $12,420.00 in StockGeneration Bio Co. (NASDAQ:GBIO) Insider Sells $12,420.00 in Stock
americanbankingnews.com - May 12 at 5:40 PM
Generation Bio (NASDAQ:GBIO) Shares Gap Up to $30.85Generation Bio (NASDAQ:GBIO) Shares Gap Up to $30.85
americanbankingnews.com - May 12 at 11:30 AM
Generation Bio (NASDAQ:GBIO) Shares Gap Down to $32.36Generation Bio (NASDAQ:GBIO) Shares Gap Down to $32.36
americanbankingnews.com - May 10 at 4:38 PM
Generation Bio Co. (NASDAQ:GBIO) Receives Average Rating of "Buy" from BrokeragesGeneration Bio Co. (NASDAQ:GBIO) Receives Average Rating of "Buy" from Brokerages
americanbankingnews.com - May 4 at 8:54 AM
Generation Bio Co (GBIO)Generation Bio Co (GBIO)
investing.com - April 30 at 3:37 PM
Generation Bio to Present at American Society of Gene & Cell Therapy 2021 Virtual Annual MeetingGeneration Bio to Present at American Society of Gene & Cell Therapy 2021 Virtual Annual Meeting
finance.yahoo.com - April 27 at 7:05 PM
Generation Bio Co. (NASDAQ:GBIO) Insider Sells $97,650.00 in StockGeneration Bio Co. (NASDAQ:GBIO) Insider Sells $97,650.00 in Stock
americanbankingnews.com - April 24 at 7:12 PM
Do Generation Bio Co. (NASDAQ:GBIO) Provide Stability And Growth?Do Generation Bio Co. (NASDAQ:GBIO) Provide Stability And Growth?
stocksregister.com - April 24 at 2:11 PM
Generation Bio (NASDAQ:GBIO) Trading Down 3%Generation Bio (NASDAQ:GBIO) Trading Down 3%
americanbankingnews.com - April 23 at 12:52 PM
Check this Generation Bio Co. (NASDAQ:GBIO) Analysis Before You InvestCheck this Generation Bio Co. (NASDAQ:GBIO) Analysis Before You Invest
stocksregister.com - April 17 at 1:18 PM
Generation Bio to Present at 20th Annual Needham Virtual Healthcare ConferenceGeneration Bio to Present at 20th Annual Needham Virtual Healthcare Conference
finance.yahoo.com - April 8 at 8:03 AM
GBIO Makes Bullish Cross Above Critical Moving AverageGBIO Makes Bullish Cross Above Critical Moving Average
nasdaq.com - April 1 at 5:50 PM
Generation Bio Co. (NASDAQ:GBIO) is up 1.16% year-to-date, analysts forecast major price rallyGeneration Bio Co. (NASDAQ:GBIO) is up 1.16% year-to-date, analysts forecast major price rally
stocksregister.com - March 27 at 5:43 PM
Generation Bio Reports Fourth Quarter and Full Year 2020 Financial ResultsGeneration Bio Reports Fourth Quarter and Full Year 2020 Financial Results
finance.yahoo.com - March 18 at 9:19 AM
Why Earnings Season Could Be Great for Generation Bio (GBIO)Why Earnings Season Could Be Great for Generation Bio (GBIO)
finance.yahoo.com - March 1 at 12:25 PM
Generation Bio Appoints Ron Cooper to Its Board of DirectorsGeneration Bio Appoints Ron Cooper to Its Board of Directors
finance.yahoo.com - February 18 at 7:38 AM
Generation Bio Co. (NASDAQ:GBIO) Jumps 7%: What Could Be on the Way Going Forward?Generation Bio Co. (NASDAQ:GBIO) Jumps 7%: What Could Be on the Way Going Forward?
stocksregister.com - February 7 at 11:09 PM
Trade Alert: The Independent Director Of Generation Bio Co. (NASDAQ:GBIO), Charles Rowland, Has Just Spent US$500k Buying 25% More SharesTrade Alert: The Independent Director Of Generation Bio Co. (NASDAQ:GBIO), Charles Rowland, Has Just Spent US$500k Buying 25% More Shares
finance.yahoo.com - January 14 at 4:40 PM
Generation Bio Announces Closing of Public OfferingGeneration Bio Announces Closing of Public Offering
finance.yahoo.com - January 11 at 7:12 PM
Generation Bio Announces Pricing of Public OfferingGeneration Bio Announces Pricing of Public Offering
finance.yahoo.com - January 6 at 11:10 PM
DateCompanyBrokerageAction
5/13/2021Heron TherapeuticsStifel NicolausReiterated Rating
12/2/2020Heron TherapeuticsSVB LeerinkBoost Price Target
8/6/2020Heron TherapeuticsNorthland SecuritiesInitiated Coverage
5/26/2020Heron TherapeuticsGuggenheimInitiated Coverage
5/18/2020Heron TherapeuticsFIXInitiated Coverage
4/15/2020Heron TherapeuticsNeedham & Company LLCReiterated Rating
2/20/2020Heron TherapeuticsCantor FitzgeraldReiterated Rating
1/15/2020Heron TherapeuticsCowenReiterated Rating
10/3/2019Heron TherapeuticsJMP SecuritiesLower Price Target
8/13/2019Heron TherapeuticsEvercore ISIReiterated Rating
5/13/2021Myovant SciencesCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellLower Price Target
5/3/2021Myovant SciencesJPMorgan Chase & Co.Lower Price Target
1/6/2021Myovant SciencesThe Goldman Sachs GroupDowngrade
12/21/2020Myovant SciencesRobert W. BairdBoost Price Target
5/17/2021ADC TherapeuticsMorgan StanleyLower Price Target
5/14/2021ADC TherapeuticsHC WainwrightLower Price Target
6/9/2020ADC TherapeuticsBank of AmericaInitiated Coverage
9/14/2020Harmony BiosciencesJefferies Financial GroupInitiated Coverage
9/14/2020Harmony BiosciencesPiper SandlerInitiated Coverage
3/1/2021Generation BioWilliam BlairInitiated Coverage
7/7/2020Generation BioWedbushInitiated Coverage
(Data available from 5/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.